Quincy Medical Group Completes First Inspire Therapy Procedure

July 15, 2020

Dr. Abra­ham Sheffield, Ear, Nose, and Throat (ENT) physi­cian at Quin­cy Med­ical Group (QMG), has com­plet­ed the first Inspire implant pro­ce­dure in the Quin­cy, IL area. Inspire is an FDA-approved obstruc­tive sleep apnea (OSA) treat­ment option for peo­ple who can­not use Con­tin­u­ous Pos­i­tive Air­way Pres­sure (CPAP) therapy.

OSA affects 22 mil­lion Amer­i­cans. When left untreat­ed, OSA can cause vehi­cle and work­place acci­dents, wors­en­ing mood and mem­o­ry, stroke, heart attack, and even death. It occurs when the air­way col­laps­es dur­ing sleep and blocks the flow of oxy­gen to the brain. The brain sens­es a lack of oxy­gen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats through­out the night and caus­es poor, dis­rup­tive sleep.

Inspire implant ther­a­py works inside the body with a patient’s nat­ur­al breath­ing process to treat sleep apnea. Mild stim­u­la­tion keeps the air­way open dur­ing sleep, allow­ing oxy­gen to flow nat­u­ral­ly. The patient uses a small hand­held remote to turn the Inspire sys­tem on before bed and off when they wake up.

The Inspire sys­tem is implant­ed dur­ing a short, out­pa­tient pro­ce­dure. The sys­tem is placed under the skin of the neck and chest through three small inci­sions. Most patients return home the same day and take over-the-counter pain med­ica­tions to man­age pain as needed.

The safe­ty and effi­ca­cy of Inspire was eval­u­at­ed dur­ing the STAR clin­i­cal tri­al. Five-year STAR tri­al out­comes show patients using Inspire expe­ri­ence sig­nif­i­cant reduc­tions in sleep apnea events and sig­nif­i­cant improve­ments in qual­i­ty of life mea­sures. As of May 2020, there have been over 100 peer-reviewed pub­li­ca­tions on Inspire. These pub­li­ca­tions show results con­sis­tent with those seen in the STAR trial.

We are excit­ed to have com­plet­ed the first Inspire pro­ce­dure in the Quin­cy, IL area,” said Dr. Sheffield. Inspire rep­re­sents a sig­nif­i­cant advance­ment in treat­ing sleep apnea. It is a great option for patients with mod­er­ate or severe sleep apnea who are unable or do not want to wear a CPAP. It has high lev­els of patient sat­is­fac­tion and ther­a­py adherence.”

To learn more about Inspire at QMG, vis­it https://​quin​cymed​group​.com/​i​n​s​p​i​r​e​s​leep/.